Aventis Licenses Ingenuity's Products for Drug Discovery

Aventis Is Deploying Both the Ingenuity Pathways Analysis Application for Biologists and Ingenuity Pathways Knowledge Base for Bioinformaticians

11.02.2004

Anzeigen

Software zur Überprüfung der Bildintegrität - authentifizieren Sie Ihre Bilder für die Veröffentlichung

Effiziente Größenausschluss-Chromatographie mit YMC-SEC MAB

High-Throughput-Screening von 1536 Proben in nur 27 Sekunden: Der schnellste Microplate-Reader im Markt

Ingenuity announced that Aventis has licensed the Ingenuity Pathways Analysis application for use by its biologists to better understand the biology underlying experimental datasets. Aventis also licensed the Ingenuity Pathways Knowledge Base to enable its bioinformaticians to create proprietary systems biology solutions for internal use.

Ingenuity Pathways Analysis is a web-delivered application that enables biologists to explore, understand, and discover therapeutically relevant networks significant to their experiment results.

"The Ingenuity Pathways Knowledge Base is the world's largest manually curated biological database created from millions of individually modeled relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases," said Frank C. Mara, Senior Vice President of Ingenuity. "This product is distinctive in its unrivaled computational capabilities enabled through its highly structured ontology, unsurpassed quality of data, and genome-scale coverage. We are pleased Aventis has chosen Ingenuity."

https://www.bionity.com/de/news/35124/aventis-licenses-ingenuity-s-products-for-drug-discovery.html